IM Bennani-Baiti - Publications

Affiliations: 
Molecular Biology Memorial Sloan-Kettering Cancer Center, Rockville Centre, NY, United States 
 Human Genetics University of Pennsylvania Perelman School of Medicine 
 Howard Hughes Medical Institute, Chevy Chase, MD, United States 
 Fox Chase Cancer Center 
 Saint Louis University School of Medicine, St. Louis, MO, United States 
 2016- President & CEO Cancer Epigenetics Society (CES) 
Area:
Cancer, Epigenetics, Gene regulation, Cancer biomarkers, Cancer therapy

0/17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
Low-probability matches (unlikely to be authored by this person)
2012 Bennani-Baiti B, Bennani-Baiti IM. Gene symbol precision. Gene. 491: 103-9. PMID 22019431 DOI: 10.1016/j.gene.2011.09.035  0.252
2011 Bennani-Baiti IM, Aryee DN, Ban J, Machado I, Kauer M, Mühlbacher K, Amann G, Llombart-Bosch A, Kovar H. Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma. The Journal of Pathology. 225: 353-63. PMID 21984123 DOI: 10.1002/path.2966  0.237
2010 Aryee DN, Niedan S, Kauer M, Schwentner R, Bennani-Baiti IM, Ban J, Muehlbacher K, Kreppel M, Walker RL, Meltzer P, Poremba C, Kofler R, Kovar H. Hypoxia modulates EWS-FLI1 transcriptional signature and enhances the malignant properties of Ewing's sarcoma cells in vitro. Cancer Research. 70: 4015-23. PMID 20442286 DOI: 10.1158/0008-5472.Can-09-4333  0.221
2012 Bennani-Baiti IM, Machado I, Llombart-Bosch A, Kovar H. Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma. Human Pathology. 43: 1300-7. PMID 22245111 DOI: 10.1016/j.humpath.2011.10.010  0.213
2009 Richter GH, Plehm S, Fasan A, Rössler S, Unland R, Bennani-Baiti IM, Hotfilder M, Löwel D, von Luettichau I, Mossbrugger I, Quintanilla-Martinez L, Kovar H, Staege MS, Müller-Tidow C, Burdach S. EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation. Proceedings of the National Academy of Sciences of the United States of America. 106: 5324-9. PMID 19289832 DOI: 10.1073/pnas.0810759106  0.188
2016 Toegel S, Weinmann D, André S, Walzer SM, Bilban M, Schmidt S, Chiari C, Windhager R, Krall C, Bennani-Baiti IM, Gabius HJ. Galectin-1 Couples Glycobiology to Inflammation in Osteoarthritis through the Activation of an NF-κB-Regulated Gene Network. Journal of Immunology (Baltimore, Md. : 1950). PMID 26792806 DOI: 10.4049/jimmunol.1501165  0.177
2016 Liersch-Löhn B, Slavova N, Buhr HJ, Bennani-Baiti IM. Differential protein expression and oncogenic gene network link tyrosine kinase ephrin B4 receptor to aggressive gastric and gastroesophageal junction cancers. International Journal of Cancer. 138: 1220-31. PMID 26414866 DOI: 10.1002/ijc.29865  0.166
2011 Bennani-Baiti IM. Epigenetic and epigenomic mechanisms shape sarcoma and other mesenchymal tumor pathogenesis. Epigenomics. 3: 715-32. PMID 22126291 DOI: 10.2217/epi.11.93  0.16
2015 Bennani-Baiti B, Toegel S, Viernstein H, Urban E, Noe CR, Bennani-Baiti IM. Inflammation Modulates RLIP76/RALBP1 Electrophile-Glutathione Conjugate Transporter and Housekeeping Genes in Human Blood-Brain Barrier Endothelial Cells. Plos One. 10: e0139101. PMID 26406496 DOI: 10.1371/journal.pone.0139101  0.155
2008 Ban J, Bennani-Baiti IM, Kauer M, Schaefer KL, Poremba C, Jug G, Schwentner R, Smrzka O, Muehlbacher K, Aryee DN, Kovar H. EWS-FLI1 suppresses NOTCH-activated p53 in Ewing's sarcoma. Cancer Research. 68: 7100-9. PMID 18757425 DOI: 10.1158/0008-5472.CAN-07-6145  0.153
1995 Bennani-Baiti IM, Jones BK, Liebhaber SA, Cooke NE. Physical linkage of the human growth hormone gene cluster and the skeletal muscle sodium channel alpha-subunit gene (SCN4A) on chromosome 17. Genomics. 29: 647-52. PMID 8575757 DOI: 10.1006/Geno.1995.9954  0.142
2010 Bennani-Baiti IM, Cooper A, Lawlor ER, Kauer M, Ban J, Aryee DN, Kovar H. Intercohort gene expression co-analysis reveals chemokine receptors as prognostic indicators in Ewing's sarcoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 3769-78. PMID 20525755 DOI: 10.1158/1078-0432.Ccr-10-0558  0.135
2015 Bennani-Baiti N, Bennani-Baiti IM. Cancer Bioinformatic Methods to Infer Meaningful Data From Small-Size Cohorts. Cancer Informatics. 14: 131-9. PMID 26568679 DOI: 10.4137/CIN.S32696  0.125
2012 Bennani-Baiti IM. Integration of ERα-PELP1-HER2 signaling by LSD1 (KDM1A/AOF2) offers combinatorial therapeutic opportunities to circumventing hormone resistance in breast cancer. Breast Cancer Research : Bcr. 14: 112. PMID 22992372 DOI: 10.1186/bcr3249  0.121
1993 Bennani-Baiti IM, Lafarge-Frayssinet C, Herscovici J, Monserret R, Robbana-Barnat S, Antonakis K, Frayssinet C, Uriel J. In vitro evaluation of the differential cytotoxicity of keto-C-glycosides toward normal and malignant cells. Anticancer Research. 13: 467-73. PMID 8517664  0.112
2000 Torigoi E, Bennani-Baiti IM, Rosen C, Gonzalez K, Morcillo P, Ptashne M, Dorsett D. Chip interacts with diverse homeodomain proteins and potentiates bicoid activity in vivo. Proceedings of the National Academy of Sciences of the United States of America. 97: 2686-91. PMID 10688916 DOI: 10.1073/pnas.050586397  0.093
2020 Bennani NN, Bennani-Baiti IM. Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 31: 1585-1586. PMID 32822832 DOI: 10.1016/j.annonc.2020.08.2095  0.043
Hide low-probability matches.